King Pharmaceuticals KG AmTrust Reinsurance — Percent share of losses net of reinsurance

Similar metrics at other companies

ACGLReinsurance — Percentage of Amount Assumed to Net

33.7%+0.9pp

CIAAccident and Health Insurance, Excluding Workers' Compensation — Reinsurance, Reinsured Risk, Percentage

100%0.0pp

WRBReinsurance & Monoline Excess — Percentage of Amount Assumed to Net

18%-0.7pp

METLife and Other — Net amount at risk percentage after taking reinsurance into consideration

99%+1.0pp

ESN

ESNTPercentage of Amount Assumed to Net

0%—

WRBInsurance — Percentage of Amount Assumed to Net

0.7%+0.1pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept kg:PercentShareOfLossNetOfReinsurance.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's amtrust reinsurance — percent share of losses net of reinsurance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's amtrust reinsurance — percent share of losses net of reinsurance?: King Pharmaceuticals (KG) reported amtrust reinsurance — percent share of losses net of reinsurance of 10% in Q4 2025.
What does amtrust reinsurance — percent share of losses net of reinsurance mean?: Reflects the proportion of insurance losses retained by the segment after accounting for recoveries from reinsurance agreements. It is a key indicator of the segment's net risk exposure and the efficacy of its risk transfer programs.